Beschrijving
Which statin side effects are supported by blinded trials?
Blinded-trial evidence supported increased liver-test abnormalities but did not show excess risk for most other outcomes attributed to statins in product labels. Previously established muscle and diabetes risks remain clinically relevant.
This episode discusses a meta-analysis, not a single randomised trial.
Reference: Cholesterol Treatment Trialists’ (CTT) Collaboration. Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials. Lancet…
Website: listen.hubhopper.com

